(Total Views: 604)
Posted On: 12/07/2021 7:01:16 AM
Post# of 148899
Quote:
It seems almost more logarithmic than linear efficiency increase regarding CTCs.
More than likely that is true. We know there's 100% receptor occupancy at 700mg. There is probably an excess of leronlimab that will cover new CCR5 receptors that are popping up. Even if there's 90% peak receptor occupancy at 350% the new CCR5 receptors won't be bound. After peak RO is achieved the RO will decrease between shots.
(3)
(0)Scroll down for more posts ▼
